医院层面医疗补助覆盖率与无症状颈动脉术后住院时间延长的关联
基于美国国家住院样本2006-2014年数据,纳入984283例无症状颈动脉狭窄行颈动脉内膜剥脱术(88%)或颈动脉支架置入术(12%)的患者。医院层面医疗补助覆盖率越高,术后住院时间>1天的风险越高,但主要并发症和死亡率无差异。
要点
- 高医疗补助覆盖率医院CEA后住院时间>1天风险增加(OR 1.66)。
- 高医疗补助覆盖率医院CAS后住院时间>1天风险增加(OR 1.42)。
- 各医疗补助覆盖率组间神经、心脏并发症及死亡率相似。
核心结论
- 医院层面医疗补助覆盖率较高与无症状颈动脉狭窄CEA和CAS术后住院时间延长相关。
- 价值支付模型应调整医院层面医疗补助覆盖率以合理补偿高覆盖率机构。
研究设计与样本
- 回顾性队列研究,查询美国国家住院样本2006-2014年数据。
- 纳入984283例无症状颈动脉狭窄行CEA(88%)或CAS(12%)的患者。
- 按医院层面医疗补助覆盖率四分位数分为低、中、高三组。
主要发现
- CEA后平均住院时间在低、中、高覆盖率医院分别为1.4±1.5、2.1±2.5、2.2±2.8天(P=0.0001)。
- CAS后平均住院时间在低、中、高覆盖率医院分别为1.7±2.6、1.8±2.1、2±2.6天(P<0.0001)。
- CEA后中覆盖率(OR 1.62,95%CI 1.17-2.24)和高覆盖率(OR 1.66,95%CI 1.2-2.28)与住院时间>1天风险增加相关(P=0.009)。
- CAS后高覆盖率与住院时间>1天风险增加相关(OR 1.42,95%CI 1.06-1.91)(P=0.003)。
- CEA后神经并发症(0.8% vs. 0.9% vs. 0.9%,P=0.83)和心脏并发症(0.9% vs. 1.2% vs. 1.2%,P=0.24)在三组间相似。
临床怎么用
- 临床医生应关注高医疗补助覆盖率医院术后住院时间可能延长的现象。
- 价值支付模型应考虑调整医院层面医疗补助覆盖率以合理补偿。
- 需调查护理路径和系统改进以帮助减少住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Length of stay (LOS) after carotid endarterectomy (CEA) and carotid artery stenting (CAS) for asymptomatic disease is used as a quality measure and affects hospital operating margins. Patient-level Medicaid status has traditionally been associated with longer hospital LOS. Our goal was to assess the association between hospital-level Medicaid prevalence and postoperative LOS after CEA and CAS. METHODS: The National Inpatient Sample was queried from 2006-2014 for CEA and CAS performed for asymptomatic carotid stenosis. Overall hospital-level Medicaid prevalence was divided into quartiles. The quartiles were further categorized into low Medicaid prevalence (LM) (lowest quartile), medium Medicaid prevalence (MM) (second and third quartiles), and high Medicaid prevalence (HM) (fourth quartile) cohorts. The primary outcome evaluated was postoperative LOS >1 day. The secondary outcomes included perioperative/in-hospital complications and mortality. RESULTS: There were 984,283 patients with asymptomatic carotid stenosis who underwent CEA (88%) or CAS (12%). Mean postoperative LOS after CEA at hospitals with LM, MM, and HM prevalence was 1.4 ± 1.5, 2.1 ± 2.5, and 2.2 ± 2.8 days (P = 0.0001), respectively, and after CAS were 1.7 ± 2.6, 1.8 ± 2.1, and 2 ± 2.6 days (P < 0.0001), respectively. After CEA, relative to LM prevalence, MM (OR 1.62, 95% CI 1.17-2.24) and HM (OR 1.66, 95% CI 1.2-2.28) prevalence were associated with a higher likelihood of LOS > 1 day (P = 0.009). After CAS, relative to LM prevalence, HM prevalence was associated with a higher likelihood of LOS >1 day (OR 1.42, 95% CI 1.06-1.91) (P = 0.003). After CEA, neurologic (0.8% vs. 0.9% vs. 0.9%, P = 0.83) and cardiac complications (0.9% vs. 1.2% vs. 1.2%, P = 0.24) were similar among hospitals with LM, MM, and HM prevalence, respectively. After CAS, the prevalence of neurological (1.1% vs. 1% vs. 1.2%, P = 0.42) and cardiac complications (2% vs. 1.3% vs. 1.5%, P = 0.46) were also similar. After both CEA and CAS, mortality was similar among Medicaid prevalence cohorts. CONCLUSIONS: Higher hospital-level Medicaid prevalence was associated with longer LOS after CEA and CAS for asymptomatic carotid stenosis. Value-based payment models should adjust for hospital-level Medicaid prevalence to appropriately reimburse providers and hospital with higher Medicaid prevalence as well as investigate care pathways and systems improvement to help reduce LOS.
引用
- Siracuse JJ, Farber A, Cheng TW, et al. Hospital-Level Medicaid Prevalence Is Associated with Increased Length of Stay after Asymptomatic Carotid Endarterectomy and Stenting Despite no Increase in Major Complications. Ann Vasc Surg. 2020. PMID: 32949743. doi:10.1016/j.avsg.2020.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。